KYOTO HEALTH ANNOUNCED ON 1 APRIL 2024 THAT IT HAS GRANTED APPROXIMATELY 3,210,620 NEW SHARES, REPRESENTING 0.10% OF THE TOTAL SHARES ISSUED, TO EMPLOYEES AND SENIOR MANAGEMENT PERSONNEL OF THE GROUP (EXCLUDING THE GROUP DIRECTORS) UNDER THE INITIAL PUBLIC OFFERING POST-IPO SHARE REWARD SCHEME. The market price of the award shares is HK$27.70 per share and will be vested in the grantor within 1 to 4 years. This initiative aims to align the interests of grantors with those of the Group through share ownership, dividends and other distributions and to encourage them to contribute to the long-term growth and development of the Group. The award is not accompanied by performance targets, but takes into account the grantor's direct contribution to the Group's...Show More

KYOTO HEALTH ANNOUNCED ON 1 APRIL 2024 THAT IT HAS GRANTED APPROXIMATELY 3,210,620 NEW SHARES, REPRESENTING 0.10% OF THE TOTAL SHARES ISSUED, TO EMPLOYEES AND SENIOR MANAGEMENT PERSONNEL OF THE GROUP (EXCLUDING THE GROUP DIRECTORS) UNDER THE INITIAL PUBLIC OFFERING POST-IPO SHARE REWARD SCHEME. The market price of the award shares is HK$27.70 per share and will be vested in the grantor within 1 to 4 years. This initiative aims to align the interests of grantors with those of the Group through share ownership, dividends and other distributions and to encourage them to contribute to the long-term growth and development of the Group. The award is not accompanied by performance targets, but takes into account the grantor's direct contribution to the Group's business performance and sustainability. Bonus shares may be forfeited or written off if the grantor violates certain conditions, such as committing a criminal offence or causing harm to the interests of the Group. Once the new shares have been issued and distributed, they will have the same rights as the issued paid-in shares.